Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodrigo O Perez

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Lancet (London, England)|July 7, 2018
Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry studyMaxime J M van der Valk, Denise E Hilling, Esther Bastiaannet, et al.
Cancer Genetics|May 13, 2015
Comprehensive evaluation of the effectiveness of gene expression signatures to predict complete response to neoadjuvant chemoradiotherapy and guide surgical intervention in rectal cancerCamila Lopes-Ramos, Fernanda C Koyama, Angelita Habr-Gama, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2012
Optimal timing for assessment of tumor response to neoadjuvant chemoradiation in patients with rectal cancer: do all patients benefit from waiting longer than 6 weeks?Rodrigo O Perez, Angelita Habr-Gama, Guilherme P São Julião, et al.
Diseases of the Colon and Rectum|May 3, 2024
An International Expert-Based Consensus on the Definition of a Clinical Near-Complete Response After Neoadjuvant (Chemo)radiotherapy for Rectal CancerPetra A Custers, Geerard L Beets, Simon P Bach, et al.
Diseases of the Colon and Rectum|July 26, 2023
Rectal Cancer and Organ-Preservation: Safety First, Then the KingLaura M Fernandez, Guilherme P São Julião, Andrew G Renehan, et al.
Diseases of the Colon and Rectum|December 14, 2022
The Risk of Distant Metastases in Patients With Clinical Complete Response Managed by Watch and Wait After Neoadjuvant Therapy for Rectal Cancer: The Influence of Local Regrowth in the International Watch and Wait DatabaseLaura M Fernandez, Guilherme P São Julião, Andrew G Renehan, et al.
The British Journal of Surgery|November 5, 2021
Watch and wait after a clinical complete response in rectal cancer patients younger than 50 yearsRenu R Bahadoer, Koen C M J Peeters, Geerard L Beets, et al.
The Lancet. Oncology|December 14, 2020
Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry studyLaura M Fernandez, Guilherme P São Julião, Nuno L Figueiredo, et al.
Oncotarget|September 7, 2014
Mutational analysis of genes coding for cell surface proteins in colorectal cancer cell lines reveal novel altered pathways, druggable mutations and mutated epitopes for targeted therapyElisa Donnard, Paula F Asprino, Bruna R Correa, et al.
The British Journal of Surgery|October 11, 2023
Stoma-free survival after anastomotic leak following rectal cancer resection: worldwide cohort of 2470 patientsNynke G Greijdanus, Kiedo Wienholts, Sander Ubels, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Lancet (London, England)|July 7, 2018
Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry studyMaxime J M van der Valk, Denise E Hilling, Esther Bastiaannet, et al.
Cancer Genetics|May 13, 2015
Comprehensive evaluation of the effectiveness of gene expression signatures to predict complete response to neoadjuvant chemoradiotherapy and guide surgical intervention in rectal cancerCamila Lopes-Ramos, Fernanda C Koyama, Angelita Habr-Gama, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2012
Optimal timing for assessment of tumor response to neoadjuvant chemoradiation in patients with rectal cancer: do all patients benefit from waiting longer than 6 weeks?Rodrigo O Perez, Angelita Habr-Gama, Guilherme P São Julião, et al.
Diseases of the Colon and Rectum|May 3, 2024
An International Expert-Based Consensus on the Definition of a Clinical Near-Complete Response After Neoadjuvant (Chemo)radiotherapy for Rectal CancerPetra A Custers, Geerard L Beets, Simon P Bach, et al.
Diseases of the Colon and Rectum|July 26, 2023
Rectal Cancer and Organ-Preservation: Safety First, Then the KingLaura M Fernandez, Guilherme P São Julião, Andrew G Renehan, et al.
Diseases of the Colon and Rectum|December 14, 2022
The Risk of Distant Metastases in Patients With Clinical Complete Response Managed by Watch and Wait After Neoadjuvant Therapy for Rectal Cancer: The Influence of Local Regrowth in the International Watch and Wait DatabaseLaura M Fernandez, Guilherme P São Julião, Andrew G Renehan, et al.
The British Journal of Surgery|November 5, 2021
Watch and wait after a clinical complete response in rectal cancer patients younger than 50 yearsRenu R Bahadoer, Koen C M J Peeters, Geerard L Beets, et al.
The Lancet. Oncology|December 14, 2020
Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry studyLaura M Fernandez, Guilherme P São Julião, Nuno L Figueiredo, et al.
Oncotarget|September 7, 2014
Mutational analysis of genes coding for cell surface proteins in colorectal cancer cell lines reveal novel altered pathways, druggable mutations and mutated epitopes for targeted therapyElisa Donnard, Paula F Asprino, Bruna R Correa, et al.
The British Journal of Surgery|October 11, 2023
Stoma-free survival after anastomotic leak following rectal cancer resection: worldwide cohort of 2470 patientsNynke G Greijdanus, Kiedo Wienholts, Sander Ubels, et al.
Pageof 8